Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25951 | 21274866 | Hepatology | Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. | 2010 | Details |
| A25963 | 21258197 | Korean J Gastroenterol | Validation of P2/MS and other noninvasive fibrosis scoring systems in the Korean population with nonalcoholic fatty liver disease. | 2011 | Details |
| A25964 | 21256907 | J Hepatol | Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25969 | 21254180 | Hepatology | Noninvasive assessment of liver fibrosis. | 2010 | Details |
| A25973 | 21250982 | Eur J Clin Invest | Altered distribution of caveolin-1 in early liver steatosis. | 2011 | Details |
| A25975 | 21248661 | Transplantation | NAFLD recurrence in liver transplant recipients. | 2011 | Details |
| A25977 | 21245286 | Drug Metab Dispos | Hepatic pharmacokinetics of cationic drugs in a high-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2011 | Details |
| A25981 | 21240032 | Pancreas | Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. | 2011 | Details |
| A25983 | 21240012 | J Pediatr Gastroenterol Nutr | Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease. | 2011 | Details |
| A25984 | 21238518 | J Hepatol | C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. | 2011 | Details |
| A25988 | 21233280 | Am J Physiol Gastrointest Liver Physiol | Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. | 2011 | Details |
| A25992 | 21227598 | Pathol Res Pract | Experimental study of non-alcoholic fatty liver disease (NAFLD) on a model of starving chickens: is generalization of steatosis accompanied by fibrosis of the liver tissue? | 2011 | Details |
| A25994 | 21199528 | J Gastroenterol Hepatol | Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. | 2011 | Details |
| A25996 | 21225497 | Pol J Pathol | Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. | 2010 | Details |
| A25997 | 21225151 | Arq Gastroenterol | Experimental induction of steatosis in different tissues after the ingestion of a carbohydrate-rich diet: effect on the liver, on the heart and on indicators of oxidation. | 2011 | Details |
| A26001 | 21222589 | Curr Drug Metab | Does hepatic steatosis affect drug metabolizing enzymes in the liver? | 2011 | Details |
| A26006 | 21216209 | Endocrinol Nutr | [Fatty liver and its clinical management in obese adolescents]. | 2011 | Details |
| A26009 | 21206486 | Am J Gastroenterol | Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. | 2011 | Details |
| A26014 | 21198831 | J Gastroenterol Hepatol | Biomarkers of liver fibrosis. | 2011 | Details |
| A26015 | 21198708 | Aliment Pharmacol Ther | Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. | 2010 | Details |
| A26016 | 21198182 | J Biomed Opt | Nonlinear microscopy of lipid storage and fibrosis in muscle and liver tissues of mice fed high-fat diets. | 2011 | Details |
| A26018 | 21192835 | Proteome Sci | Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. | 2010 | Details |
| A26027 | 21190824 | J Nutr Biochem | A mouse model for nonalcoholic steatohepatitis. | 2010 | Details |
| A26028 | 21190397 | Ups J Med Sci | A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. | 2010 | Details |
| A26031 | 21184788 | J Hepatol | Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. | 2010 | Details |
| A26033 | 21184785 | J Hepatol | Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. | 2010 | Details |
| A26041 | 21176169 | BMC Med Genet | Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. | 2010 | Details |
| A26042 | 21173431 | Carcinogenesis | Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis. | 2010 | Details |
| A26043 | 21172393 | J Hepatol | Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26045 | 21168459 | J Hepatol | Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. | 2010 | Details |
| A26046 | 21168455 | J Hepatol | Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. | 2010 | Details |
| A26051 | 21166266 | Bull Mem Acad R Med Belg | Non-alcoholic fatty liver disease. | 2010 | Details |
| A26052 | 21162572 | J Agric Food Chem | Lipid fatty acid profile analyses in liver and serum in rats with nonalcoholic steatohepatitis using improved gas chromatography-mass spectrometry methodology. | 2010 | Details |
| A26054 | 21160985 | World J Hepatol | Combination drug treatment in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26055 | 21160946 | World J Hepatol | Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. | 2010 | Details |
| A26057 | 21155882 | J Gastroenterol Hepatol | Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A26058 | 21155004 | World J Gastroenterol | Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. | 2010 | Details |
| A26068 | 21145841 | J Hepatol | Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. | 2010 | Details |
| A26072 | 21145828 | J Hepatol | A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. | 2010 | Details |
| A26073 | 21145823 | J Hepatol | Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. | 2010 | Details |
| A26083 | 21130626 | Arch Pediatr | [Nonalcoholic fatty liver disease in a severely obese adolescent. An arguable liver biopsy]. | 2010 | Details |
| A26088 | 21126792 | J Hepatol | Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26093 | 21115542 | Gut | Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis. | 2010 | Details |
| A26100 | 21106424 | Ann Diagn Pathol | Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. | 2010 | Details |
| A26104 | 21091933 | J Dig Dis | Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. | 2011 | Details |
| A26113 | 21073649 | Liver Int | Angiogenesis in chronic liver disease and its complications. | 2010 | Details |
| A26116 | 21072891 | World J Gastroenterol | Histopathology of nonalcoholic fatty liver disease. | 2010 | Details |
| A26117 | 21072890 | World J Gastroenterol | Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology. | 2010 | Details |
| A26118 | 21071306 | Orv Hetil | [Fatty liver and global cardiometabolic risk]. | 2010 | Details |
| A26119 | 21071305 | Orv Hetil | [Non-alcoholic steatosis/steatohepatitis -- 2010]. | 2010 | Details |
| A26120 | 21068129 | Gut | Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. | 2010 | Details |
| A26123 | 21057163 | Ann Hepatol | G308A polymorphism of TNF-alpha gene is associated with insulin resistance and histological changes in non alcoholic fatty liver disease patients. | 2011 | Details |
| A26126 | 21055684 | Clin Liver Dis | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26127 | 21054523 | J Gastroenterol Hepatol | Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. | 2011 | Details |
| A26128 | 21054517 | J Gastroenterol Hepatol | Sophocarpine alleviates non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A26133 | 21044016 | Curr Vasc Pharmacol | Novel role of NPC1L1 in the regulation of hepatic metabolism: potential contribution of ezetimibe in NAFLD/NASH treatment. | 2011 | Details |
| A26134 | 21042922 | J Gastroenterol | The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. | 2010 | Details |
| A26137 | 21042023 | Digestion | Obesity affects the liver - the link between adipocytes and hepatocytes. | 2010 | Details |
| A26141 | 21039302 | Ann Med | Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. | 2010 | Details |
| A26147 | 21033090 | Eksp Klin Gastroenterol | [Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis]. | 2010 | Details |
| A26150 | 21033082 | Eksp Klin Gastroenterol | [Taurine in the treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
| A26158 | 20980222 | Orv Hetil | [Alterations in microRNA expression patterns in liver diseases]. | 2010 | Details |
| A26159 | 20976843 | World J Gastroenterol | Hepatic lipogranulomas in patients with chronic liver disease: association with hepatitis C and fatty liver disease. | 2010 | Details |
| A26160 | 20975341 | Am J Surg Pathol | Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. | 2010 | Details |
| A26165 | 20969475 | Antioxid Redox Signal | Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. | 2011 | Details |
| A26166 | 20967826 | Hepatology | Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. | 2010 | Details |
| A26171 | 20961734 | Nutrition | Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease. | 2010 | Details |
| A26175 | 20955971 | Best Pract Res Clin Gastroenterol | Nonalcoholic fatty liver disease. | 2010 | Details |
| A26176 | 20955440 | Aliment Pharmacol Ther | Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. | 2010 | Details |
| A26182 | 20943080 | Zhonghua Gan Zang Bing Za Zhi | [The role of heme oxygenase-1 in non-alcoholic steatohepatitis]. | 2010 | Details |
| A26186 | 20939106 | World J Gastroenterol | Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. | 2010 | Details |
| A26189 | 20938992 | Mol Nutr Food Res | Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet. | 2010 | Details |
| A26190 | 20938947 | Hepatology | Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice. | 2010 | Details |
| A26192 | 20934232 | J Hepatol | Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26193 | 20932598 | J Hepatol | Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. | 2010 | Details |
| A26195 | 20931285 | Dig Dis Sci | Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C. | 2010 | Details |
| A26197 | 20926473 | Ann Clin Biochem | Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. | 2010 | Details |
| A26200 | 20922498 | Obes Surg | NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis. | 2011 | Details |
| A26207 | 20888433 | Clin Gastroenterol Hepatol | A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. | 2010 | Details |
| A26209 | 20887595 | Hepatol Res | Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. | 2010 | Details |
| A26210 | 20883210 | Clin Sci (Lond) | A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. | 2011 | Details |
| A26220 | 20875899 | Transl Res | Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. | 2010 | Details |
| A26221 | 20875898 | Transl Res | Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach. | 2010 | Details |
| A26235 | 20850692 | Ann Diagn Pathol | Hepatocellular carcinoma arising in association with von-Meyenburg's complexes: an incidental finding or precursor lesions? A clinicopatholigic study of 4 cases. | 2010 | Details |
| A26238 | 20848203 | Dig Dis Sci | Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet. | 2010 | Details |
| A26243 | 20845385 | Biotechnol J | Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling. | 2010 | Details |
| A26244 | 20844903 | J Gastroenterol | Prevalence, gender, ethnic variations, and prognosis of NASH. | 2010 | Details |
| A26246 | 20842510 | J Gastroenterol | A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease. | 2010 | Details |
| A26248 | 20842109 | Am J Gastroenterol | Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. | 2010 | Details |
| A26249 | 20842026 | Curr Opin Clin Nutr Metab Care | Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data. | 2010 | Details |
| A26253 | 20830238 | Int J Clin Exp Pathol | Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. | 2010 | Details |
| A26257 | 20825652 | BMC Gastroenterol | Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. | 2010 | Details |
| A26258 | 20819880 | J Clin Pathol | Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease. | 2010 | Details |
| A26260 | 20818484 | Int J Mol Med | Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. | 2010 | Details |
| A26266 | 20809771 | Scand J Gastroenterol | Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. | 2010 | Details |
| A26267 | 20808246 | J Pediatr Gastroenterol Nutr | Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. | 2010 | Details |
| A26269 | 20807336 | Liver Int | Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. | 2010 | Details |
| A26274 | 20801772 | Gut | Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26280 | 20739079 | J Hepatol | Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26285 | 20731129 | Eksp Klin Gastroenterol | [The diagnostic significance of ultrasound elastometry in evaluation of fibrosis in chronic diffuse liver diseases]. | 2010 | Details |